全文获取类型
收费全文 | 38863篇 |
免费 | 5246篇 |
国内免费 | 207篇 |
专业分类
耳鼻咽喉 | 684篇 |
儿科学 | 966篇 |
妇产科学 | 885篇 |
基础医学 | 4403篇 |
口腔科学 | 1024篇 |
临床医学 | 6497篇 |
内科学 | 7450篇 |
皮肤病学 | 567篇 |
神经病学 | 4026篇 |
特种医学 | 1442篇 |
外国民族医学 | 3篇 |
外科学 | 4891篇 |
综合类 | 1143篇 |
现状与发展 | 2篇 |
一般理论 | 27篇 |
预防医学 | 4099篇 |
眼科学 | 698篇 |
药学 | 2770篇 |
1篇 | |
中国医学 | 122篇 |
肿瘤学 | 2616篇 |
出版年
2023年 | 521篇 |
2022年 | 266篇 |
2021年 | 695篇 |
2020年 | 764篇 |
2019年 | 569篇 |
2018年 | 1030篇 |
2017年 | 1013篇 |
2016年 | 1075篇 |
2015年 | 1289篇 |
2014年 | 1524篇 |
2013年 | 2243篇 |
2012年 | 2217篇 |
2011年 | 2315篇 |
2010年 | 1647篇 |
2009年 | 1602篇 |
2008年 | 2162篇 |
2007年 | 2059篇 |
2006年 | 2108篇 |
2005年 | 2146篇 |
2004年 | 1929篇 |
2003年 | 1864篇 |
2002年 | 1764篇 |
2001年 | 671篇 |
2000年 | 544篇 |
1999年 | 648篇 |
1998年 | 714篇 |
1997年 | 608篇 |
1996年 | 633篇 |
1995年 | 558篇 |
1994年 | 431篇 |
1993年 | 350篇 |
1992年 | 401篇 |
1991年 | 396篇 |
1990年 | 339篇 |
1989年 | 373篇 |
1988年 | 324篇 |
1987年 | 356篇 |
1986年 | 317篇 |
1985年 | 324篇 |
1984年 | 318篇 |
1983年 | 302篇 |
1982年 | 309篇 |
1981年 | 294篇 |
1980年 | 301篇 |
1979年 | 209篇 |
1978年 | 196篇 |
1977年 | 191篇 |
1976年 | 148篇 |
1975年 | 151篇 |
1974年 | 141篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Kara S. Tanaka MD Veronica R. Andaya BA Steven W. Thorpe MD Kenneth R. Gundle MD James B. Hayden MD Yee-Cheen Duong MD Raffi S. Avedian MD David G. Mohler MD Lee J. Morse MD Melissa N. Zimel MD Richard J. O'Donnell MD Andrew Fang MD Robert Lor Randall MD Tina H. Tran BS Christin New BA Rosanna L. Wustrack MD other members of Study Group FORCE 《Journal of surgical oncology》2023,127(1):148-158
2.
Nidogen 1 (NID1) is a glycoprotein found in basement membranes involved in cross-linking collagen IV and laminin. The role of NID in breast cancer has only been evaluated in a small number of studies and the findings of these studies have been inconsistent. Our previous work revealed that highly tumorigenic murine mammary tumor cells express high levels of Nid1 while weakly tumorigenic mammary tumor cells express low levels of Nid1. To investigate Nid1, two stable knockdown lines were created, and Nid1 knockdown was confirmed at both the mRNA and protein level. Nid1 knockdown significantly reduced cell proliferation and migration/invasion and these reductions in proliferation and migration/invasion could be rescued by conditioned media containing NID1 protein. The reduced migration/invasion observed in the Nid1 knockdown cells was not associated with significant alterations in the epithelial gene Cdh1 or the mesenchymal genes Snai1, Snai2, Twist1, Twist2, Zeb1 and Zeb2. Therefore, suppression of Nid1 expression reduces proliferation and migration/invasion in claudin-low murine mammary tumor cells. 相似文献
3.
4.
5.
ObjectivesTo fill an empirical gap in the literature by examining changes in quality of care measures occurring when multispecialty clinic systems were acquired by hospital-owned, vertically integrated health care delivery systems in the Twin Cities area.ConclusionsMoving a clinic system into a vertically integrated delivery system resulted in limited increases in quality of care indicators. Caution is warranted when the acquisition causes disruption in referral patterns. 相似文献
6.
7.
8.
目的 探讨在苯妥英钠(Phenytoin,PHT)促进大鼠牙周膜干细胞(Rat periodontal ligament stem cells,rPDLSCs)、大鼠骨髓间充质干细胞(Rat Bone Marrow Mesenchymal Stem Cells,rBMMSCs)黏附于牙骨质过程中,整合素α5β1(Integrin α5β1)起到的作用。方法 提取大鼠BMMSCs和PDLSCs,培养并纯化。通过细胞鉴定后,将获得的两种细胞各分为4组:40 mg/L PHT处理组、40 mg/L PHT+整合素α5抗体处理组、40 mg/L PHT+整合素β1抗体处理组、PBS处理组,每组细胞放入置有牙骨质片的96孔板处理4 h后,检测黏附于牙骨质片上的细胞量并做以比较。最后,利用qRT-PCR和Western blot检测40 mg/L PHT组与对照组细胞的整合素α5、β1亚基的mRNA与蛋白表达量。结果 40 mg/L PHT可促进rBMMSCs及rPDLSCs黏附于牙骨质片,加入整合素α5、β1抗体后,均明显抑制了40 mg/L PHT对rBMMSCs、rPDLSCs黏附于牙骨质的促进作用(P<0.01)。qRT-PCR、Western-blot结果显示PHT处理组的整合素α5、β1亚基表达量高于空白对照组(P<0.05)。结论 40 mg/L PHT能促进rBMMSCs、rPDLSCs黏附于牙骨质,该作用与整合素α5β1的表达上调密切相关。 相似文献
9.
10.
Anne-Marie Selzler Veronica Moore Razanne Habash Lauren Ellerton Erica Lenton Roger Goldstein 《COPD》2020,17(4):452-461
Abstract The purpose of this study was to investigate the strength of the relationships between self-efficacy and (i) functional exercise capacity and (ii) physical activity in chronic obstructive pulmonary disease (COPD), and whether self-efficacy assessment type (i.e., COPD symptoms, exercise-task, exercise-barrier, general, falls) and physical activity assessment type (i.e., self-report vs. objective) are moderators. A systematic search of COPD and self-efficacy concepts was conducted using eight databases from inception to 23 January 2019. Studies were included if they provided correlation coefficients of the relationship between self-efficacy and functional exercise capacity or physical activity, were conducted in adults diagnosed with COPD, and were published in English-language journals. A total of 14 correlation coefficients were included in the self-efficacy and functional exercise capacity meta-analysis, and 16 in the self-efficacy and physical activity meta-analysis. Data were screened, reviewed, and extracted independently by two reviewers, with discrepancies resolved by a third reviewer. Stronger self-efficacy was associated with better functional exercise capacity (weighted r?=?0.38, 95%CI [0.25, 0.50]), and greater physical activity (weighted r?=?0.25, 95%CI [0.17, 0.34]). Exercise-task self-efficacy had the strongest relationship to functional exercise capacity (weighted r?=?0.64, 95% CI [0.51, 0.73]). For physical activity, the type of self-efficacy most strongly related was inconclusive. In COPD, self-efficacy has a relationship to functional exercise capacity and physical activity, the strength of which is influenced by the choice of self-efficacy measure. An understanding of these relationships will assist clinicians in selecting the self-efficacy measure most closely related to the outcome of interest. 相似文献